CDSCO to launch online service for grant of NOCs for conducting clinical trials soon
|
Swati Rana, Mumbai
August 25 , 2016
|
|
The Central Drugs Standard Control Organisation (CDSCO) may launch
online grant of NOCs for conducting clinical trials soon, under SUGAM,
an online solution for submission, application and grant of permission,
in compliance with Union health ministry's initiative of e-governance.
The application can be submitted and monitored online which will reduce
the time of clearance.
In this regard, the CDSCO will also be
organising a hands-on workshop on 'Online process for Grant of NOC for
Clinical Trials' on August 24, 2016 at CDAC Noida and after receiving
the feedback, the date of launch will be decided, said an official from
CDSCO.
He further said the process and document required are the
same and it will reduce the time required in submitting the hard copy
to the office. The applicant can submit all the required documents and
monitor the status of the application.
The CDSCO in pursuance of
implementation of e governance has launched various services for import
of drugs, medical devices, drugs for personal use, drugs for test &
analysis and import of cosmetics in first and second phases. Now in
third phase, the online service for grant of NOCs for conducting
clinical trials will be launched.
The organisation has launched
an online portal for licensing the import of medical device from March,
under SUGAM for the import of drugs. The portal only provided benefit
for the grant of registration certificates for import of drugs or import
license of drugs and the medical device industry. Now the grant of NOC
for conducting clinical trails can also be availed.
Online
application system provides an opportunity for user to apply for the
grant through online system. It also provides an option to track the
status of application online through an application reference number
provided by the system at the time of submitting the application.
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|